计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| S613482-5mg |
5mg |
期货 ![]() |
| |
| S613482-25mg |
25mg |
期货 ![]() |
|
| 规格或纯度 | Moligand™ |
|---|---|
| 英文名称 | SC83288 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| IUPAC Name | methyl 4-[3-[[4-[(4-sulfamoylphenyl)methylsulfamoyl]phenyl]carbamoylamino]benzenecarboximidoyl]piperazine-1-carboxylate |
|---|---|
| INCHI | InChI=1S/C27H31N7O7S2/c1-41-27(36)34-15-13-33(14-16-34)25(28)20-3-2-4-22(17-20)32-26(35)31-21-7-11-24(12-8-21)43(39,40)30-18-19-5-9-23(10-6-19)42(29,37)38/h2-12,17,28,30H,13-16,18H2,1H3,(H2,29,37,38)(H2,31,32,35) |
| InChi Key | UJKWTQWUYKHLGQ-UHFFFAOYSA-N |
| Canonical SMILES | COC(=O)N1CCN(CC1)C(=N)c1cccc(c1)NC(=O)Nc1ccc(cc1)S(=O)(=O)NCc1ccc(cc1)S(=O)(=O)N |
| Isomeric SMILES | COC(=O)N1CCN(CC1)C(=N)C2=CC(=CC=C2)NC(=O)NC3=CC=C(C=C3)S(=O)(=O)NCC4=CC=C(C=C4)S(=O)(=O)N |
| PubChem CID | 57496162 |
| 1. Pegoraro S, Duffey M, Otto TD, Wang Y, Rösemann R, Baumgartner R, Fehler SK, Lucantoni L, Avery VM, Moreno-Sabater A et al.. (2017) SC83288 is a clinical development candidate for the treatment of severe malaria.. Nat Commun, 8 (14193). [PMID:28139658] |
| 2. Duffey M, Sanchez CP, Lanzer M. (2018) Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.. Malar J, 17 (1): (121). [PMID:29558913] |